
JNJ’s Business Health & Remote Office Politics 7/19/22
Johnson & Johnson beat analysts’ estimates on the strength of its pharmaceuticals unit despite the company cutting its profit forecast due to a stronger dollar. CFO Joseph Wolk blamed the forecast cut on currency fluctuations, pointing to the parity between the euro and the dollar. As the job market starts to cool down and companies begin to look for ways to save with a possible recession on the horizon, there is a renewed return-to-office debate. CNBC’s Hugh Son reports on slowed hiring at Goldman Sachs, and Harvard Business School professor Tsedal Neeley whether business leaders need to…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.